Hal Braley

CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common beta chain of the IL-3, GM-CSF and IL-5 receptors

Con Panousis, Urmi Dhagat, Kirsten M Edwards, Veronika Rayzman, Matthew P Hardy, Hal Braley, Gail M Gauvreau, Timothy R Hercus, Steven Smith, Roma Sehmi, Laura McMillan, Mara Dottore, Barbara J McClure, Louis J Fabri, Gino Vairo, Angel F Lopez, Michael W Parker, Andrew D Nash, Nicholas J Wilson, Michael J Wilson, et al.

Journal article  |  2016  |  MABS

Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCC

SJ Busfield, M Biondo, M Wong, HS Ramshaw, EM Lee, S Ghosh, H Braley, C Panousis, AW Roberts, SZ He, D Thomas, L Fabri, G Vairo, RB Lock, AF Lopez, AD Nash

Journal article  |  2014  |  Leukemia